Article metrics

Download PDFPDF

430 A phase 1b/II clinical study of AK112, a PD-1/VEGF bispecific antibody, in combination with olaparib in BRCA germline wild-type platinum sensitive recurrent ovarian cancer
Free

 

Online download statistics by month:

Online download statistics by month: November 2021 to April 2024

AbstractFullPdf
Nov 2021528031
Dec 20219009
Jan 202268018
Feb 2022122012
Mar 2022247011
Apr 202272013
May 202255017
Jun 202249016
Jul 202243012
Aug 202242012
Sep 202249024
Oct 202266019
Nov 202229018
Dec 202243017
Jan 20233006
Feb 202336017
Mar 202339018
Apr 202334012
May 20231606
Jun 202316012
Jul 202324017
Aug 202353019
Sep 202326015
Oct 202346015
Nov 202336014
Dec 20238009
Jan 20243009
Feb 20245406
Mar 202482010
Apr 202444011
Total21490425